News

Individuals without their own prescriptions may be at risk for overdose if they have access to family members’ drugs, according to a new study

While FDA recently said Novartis and AveXis did not reveal data on their $2.1 million gene thaerpy for pediatric spinal muscular atrophy until after it was approved, Novartis is defending its actions.

Experts provide 14 ways that insurers can improve their members’ experiences with them.

How payers and health systems are using wearables to monitor patient health and encourage healthy behaviors.

The state of telemedicine and remote patient monitoring.

Two challenges providers may face under the proposed rule.

MS is in need of new medications-these could be the future.

Opportunities to lower drug prices, as promised by President Trump’s American Patients First Blueprint, are picking up steam, some progressing more quickly than others.

What are some of the implications of executive order on transparency in healthcare?

Patient experience should take a front seat at healthcare organizations, but what does that entail?

How new research shows the importance of targeted drug therapies.

A new framework for understanding individual healthcare needs.

New survey sheds light on chronic knee pain sufferer and why they don’t seek help before it’s too late.

How can healthcare organizations better overcome the challenges involved with integrating social determinants of health data into their population health initiatives?

In an effort to reduce readmissions and costs, CVS Health has launched a program to help patients with knee replacements.

Here’s what it’s going to take to succeed.

How to keep up and stay relevant in a changing market.

Managed Healthcare Executive asked some chief executives what their biggest challenge has been, and how they have worked to overcome it. Here’s what they had to say.

The first step to addressing opioid abuse for employers is to identify potential misuse and addiction.

The highest expense for many U.S. households makes this top of mind for employees.

Virtual care comes to the pharmacy chain.

Drug to treat prostate cancer is expected to produce a major windfall for two pharma makers.

FDA approved yet another indication for pembrolizumab (Keytruda) to treat patients with recurrent, locally advanced or metastatic, squamous cell carcinoma of the esophagus (ESCC).

A look at what payers are-or should be-focusing on in terms of their strategy for getting customers.

What a movie can teach you about innovation in your organization.

Where claims are coming from-and how to stop them.

Guidelines from the real-world experiences of ACO leaders.

Creating a health ecosystem for our modern-day customer-seniors with evolving healthcare needs and challenges